TIMOTHY A. SPRINGER - 19 Dec 2024 SCHEDULE 13D/A Report for Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share (RNAC)

Filing Manager: TIMOTHY A. SPRINGER
Reporting Manager: Timothy A. Springer
Security: Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: RNAC
Shares outstanding: 25,908,196 shares
Disclosed Ownership: 9,534,216 shares
Ownership: 37%
Form type: SCHEDULE 13D/A
Filing time: 23 Dec 2024, 20:22:24 UTC
Date of event: 19 Dec 2024
Next filing: 15 Jan 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	Signature	Title	CIK
Timothy A. Springer	37%	9,534,216	9,534,216	/s/ Timothy A. Springer	Timothy A. Springer	0001055624
TAS Partners LLC	2.2%	563,206	563,206	/s/ Timothy A. Springer	Timothy A. Springer/Manager	0001677543
Chafen Lu	1.4%	350,740	350,740	/s/ Chafen Lu	Chafen Lu